Try our corporate solution for free!
(212) 419-8286

Oncology or orphan drug share in approved new active substances globally 2009-2018

This statistic depicts the percentage of orphan and oncology drugs released in Canada and the PMPRB7 that were new active substances (NAS) from 2009 to 2018. According to the data, in 2018, 59 percent of approved new active substances received an orphan drug designation.

Share of orphan or oncology drugs among approved new active substances (NAS) in select countries from 2009 to 2018

Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Single Account

$39 $59 per month *
in the first 12 months
33% discount until March 31st
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$468 / Year
$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in

Release date

January 2020



Survey time period

2009 to 2018

Supplementary notes

New medicines launched between 2009 and 2014 were identified based on the date of first reported sales, while those reported for 2015 onward were determined based on the date of first-time market approval by the US Food and Drug Administration, the European Medicines Agency, and/or Health Canada.
Includes drugs launched in Canada, France, Germany, Italy, Sweden, Switzerland, United Kingdom and the United States.

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* Prices do not include sales tax.

Statistics on "Orphan drugs"

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.